Top 5 Stocks to Buy Now
→ 2,000 missiles didn't hit Iran. They hit China. (From Behind the Markets) (Ad)tc pixel Free EYPT Stock Alerts

Eyepoint Pharmaceuticals (EYPT) Short Interest Ratio & Short Volume

Eyepoint Pharmaceuticals logo
$13.71 -0.69 (-4.79%)
Closing price 06/25/2026 04:00 PM Eastern
Extended Trading
$13.70 -0.02 (-0.11%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Eyepoint Pharmaceuticals Short Interest Overview

As of June 15, 2026, Eyepoint Pharmaceuticals (EYPT) had a short interest of 15.08 million shares sold short, representing 18.96% of the public float. This marks a -0.14% decrease in short interest since the prior report. The short interest ratio (days to cover) is 13.8, meaning it would take 13.8 days of the average trading volume of 1.09 million shares to cover all short positions.

Current Short Interest
15,077,303 shares
Previous Short Interest
15,097,978 shares
Change Vs. Previous Month
-0.14%
Dollar Volume Sold Short
$182.13 million
Short Interest Ratio
13.8 Days to Cover
Last Record Date
June 15, 2026
Outstanding Shares
83,840,000 shares
Short Percent of Float
18.96%
Today's Trading Volume
1,249,697 shares
Average Trading Volume
1,094,371 shares
Today's Volume Vs. Average
114%
Short Selling Eyepoint Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Eyepoint Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

EYPT Short Interest Over Time

EYPT Days to Cover Over Time

EYPT Percentage of Float Shorted Over Time

Eyepoint Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/202615,077,303 shares $182.13 million -0.1%19.0%13.84 $12.08
5/29/202615,097,978 shares $205.03 million +6.7%19.0%15.09 $13.58
5/15/202614,152,914 shares $174.79 million -0.2%17.7%16.88 $12.35
4/30/202614,186,473 shares $187.26 million +3.9%17.7%16.59 $13.20
4/15/202613,659,042 shares $199.83 million +2.0%17.2%15.93 $14.63
3/31/202613,385,952 shares $172.54 million +7.3%16.8%14.06 $12.89
3/13/202612,478,689 shares $164.72 million +14.8%15.7%7.52 $13.20
2/27/202610,868,767 shares $190.86 million +14.1%13.6%4.51 $17.56
2/13/20269,529,005 shares $123.31 million +10.3%12.0%7.86 $12.94
1/30/20268,638,845 shares $116.80 million +4.4%10.9%9.51 $13.52
1/15/20268,272,026 shares $131.03 million -4.2%10.5%8.54 $15.84
12/31/20258,632,273 shares $157.71 million +18.1%10.9%6.61 $18.27
12/15/20257,308,090 shares $119.85 million -7.3%9.2%6.63 $16.40
11/28/20257,881,028 shares $116.88 million -8.7%10.0%7.08 $14.83
11/14/20258,632,226 shares $99.96 million +14.2%13.1%5.88 $11.58
10/31/20257,558,136 shares $98.94 million -7.0%11.5%5.85 $13.09
10/15/20258,130,000 shares $95.36 million +1.6%12.3%8.1 $11.73
9/30/20258,000,000 shares $113.92 million -10.0%N/A9.6 $14.24
9/15/20258,890,000 shares $119.21 million +5.2%N/A11.2 $13.41
8/31/20258,450,000 shares $97.77 million +9.9%12.8%11.5 $11.57
8/15/20257,690,000 shares $85.28 million +11.3%N/A9.8 $11.09
7/31/20256,910,000 shares $67.86 million +2.8%10.5%8.9 $9.82
7/15/20256,720,000 shares $66.12 million -3.0%N/A8.4 $9.84
6/30/20256,930,000 shares $65.21 million +2.8%10.5%8.3 $9.41
6/15/20256,740,000 shares $60.86 million -6.0%10.3%8.1 $9.03
5/31/20257,170,000 shares $51.70 million -0.6%11.0%8.6 $7.21
5/15/20257,210,000 shares $41.24 million -28.4%11.1%9.2 $5.72
4/30/202510,070,000 shares $68.68 million -14.8%N/A12.4 $6.82
4/15/202511,820,000 shares $67.02 million +8.1%18.2%14 $5.67
3/31/202510,930,000 shares $59.24 million +0.9%16.8%12.8 $5.42
3/15/202510,830,000 shares $70.61 million +0.9%16.7%12.6 $6.52
2/28/202510,730,000 shares $67.28 million -3.3%16.5%12.4 $6.27
2/15/202511,090,000 shares $72.09 million +3.5%17.1%12.3 $6.50
1/31/202510,720,000 shares $82.01 million +1.3%N/A11.9 $7.65
1/15/202510,580,000 shares $81.36 million +2.3%N/A11 $7.69
12/31/202410,340,000 shares $77.03 million +9.9%N/A10.8 $7.45
12/15/20249,410,000 shares $70.20 million +1.7%N/A10.3 $7.46
11/30/20249,250,000 shares $81.86 million -6.4%N/A10.8 $8.85
11/15/20249,880,000 shares $90.60 million +2.1%N/A12.2 $9.17
10/31/20249,680,000 shares $113.84 million +5.6%N/A13.1 $11.76
Where to Put $100 Before Trump's New Tech Law Rolls Out (Ad)

The Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance estimates it could unlock $400 trillion - but analyst Jeff Brown, who was consulted by Congressional offices on the legislation, believes the real figure could reach $2.6 quadrillion. Brown says this shift will pour onto a new type of investment exchange - and he's showing investors how to position themselves starting with just $100.tc pixel

Click here to see how Jeff Brown says to claim your stake
10/15/20249,170,000 shares $90.60 million +2.7%N/A15.9 $9.88
9/30/20248,930,000 shares $71.35 million -1.9%N/A13.8 $7.99
9/15/20249,100,000 shares $82.81 million -0.1%N/A12.8 $9.10
8/31/20249,110,000 shares $81.53 million -3.9%N/A12.6 $8.95
8/15/20249,480,000 shares $77.74 million -0.7%N/A11.6 $8.20
7/31/20249,550,000 shares $94.35 million -5.3%N/A10.7 $9.88
7/15/202410,080,000 shares $106.24 million +4.7%N/A8.8 $10.54
6/30/20249,630,000 shares $83.78 million +7.2%N/A8.5 $8.70
6/15/20248,980,000 shares $84.23 million +16.0%N/A8.2 $9.38
5/31/20247,740,000 shares $82.90 million -4.8%N/A6.7 $10.71
5/15/20248,130,000 shares $105.20 million +23.2%N/A7 $12.94
4/30/20246,600,000 shares $116.16 million +0.9%N/A5.6 $17.60
4/15/20246,540,000 shares $139.17 million -4.5%N/A6.7 $21.28
3/31/20246,850,000 shares $141.59 million +4.1%N/A7.1 $20.67
3/15/20246,580,000 shares $141.34 million +15.0%N/A6.4 $21.48
2/29/20245,720,000 shares $155.64 million +20.4%N/A4.5 $27.21
2/15/20244,750,000 shares $138.13 million -7.6%N/A2.9 $29.08
1/31/20245,140,000 shares $138.42 million -1.2%N/A3.3 $26.93
1/15/20245,200,000 shares $118.35 million -2.4%N/A3.5 $22.76
12/31/20235,330,000 shares $123.18 million +12.2%N/A3.9 $23.11
12/15/20234,750,000 shares $92.86 million -32.2%N/A3.6 $19.55
11/30/20237,010,000 shares $43.81 million +28.9%25.0%5.9 $6.25
11/15/20235,440,000 shares $36.39 million +1.7%19.4%10.3 $6.69
10/31/20235,350,000 shares $32.21 million +9.0%19.2%10.3 $6.02
10/15/20234,910,000 shares $39.77 million -29.3%17.6%9.3 $8.10
9/30/20236,940,000 shares $55.45 million +12.3%25.1%11.6 $7.99
9/15/20236,180,000 shares $64.77 million +9.2%22.3%10.2 $10.48
8/31/20235,660,000 shares $56.09 million +12.1%20.6%9.5 $9.91
8/15/20235,050,000 shares $71.66 million +3.7%18.8%8.9 $14.19
7/31/20234,870,000 shares $60.88 million +1.9%N/A9.3 $12.50
7/15/20234,780,000 shares $52.44 million -7.7%N/A4.9 $10.97
6/30/20235,180,000 shares $45.07 million +7.5%N/A5.6 $8.70
6/15/20234,820,000 shares $32.73 million +13.2%18.4%5.3 $6.79
5/31/20234,260,000 shares $25.77 million +5.2%16.2%4.8 $6.05
5/15/20234,050,000 shares $24.30 million +11.3%15.4%4.7 $6.00
4/30/20233,640,000 shares $22.86 million -0.3%14.1%4.4 $6.28
4/15/20233,650,000 shares $15.80 million +9.3%14.2%5.3 $4.33
3/31/20233,340,000 shares $9.82 million +19.7%13.0%11 $2.94
3/15/20232,790,000 shares $6.67 million +34.8%10.9%10 $2.39
2/28/20232,070,000 shares $6.91 million No Change8.1%8.1 $3.34
2/15/20232,070,000 shares $7.66 million -4.2%8.1%8.5 $3.70
1/31/20232,160,000 shares $10.07 million +6.9%8.6%9.3 $4.66
1/15/20232,020,000 shares $10.18 million +13.5%8.0%9.4 $5.04
12/30/20221,780,000 shares $6.23 million +6.0%7.1%12.3 $3.50
12/15/20221,680,000 shares $4.50 million -2.9%6.7%11.6 $2.68
11/30/20221,730,000 shares $5.54 million -3.4%6.9%13.6 $3.20
11/15/20221,790,000 shares $7.91 million -9.1%7.1%14.1 $4.42
10/31/20221,970,000 shares $10.64 million -1.5%N/A16.1 $5.40
10/15/20222,000,000 shares $11.20 million -1.5%7.7%14.3 $5.60
9/30/20222,030,000 shares $16.06 million -0.5%7.8%12.5 $7.91
2,000 missiles didn't hit Iran. They hit China. (Ad)

Iran sold 90% of its oil to China. Venezuela secretly shipped 80% of its exports to the same buyer. Within 60 days, America cut both supply lines - starving China's AI power grid of the cheap, endless fuel it needs to compete. Now all that energy flows through a single American chokepoint: one company, 140,000 miles of steel, and no competition. Dylan Jovine has identified the stock at the center of this strategy, along with three ascending price targets.tc pixel

See the stock name and three price targets from Dylan Jovine
9/15/20222,040,000 shares $16.30 million +0.5%7.9%12.7 $7.99
8/31/20222,030,000 shares $20.30 million +1.5%7.8%12.7 $10.00
8/15/20222,000,000 shares $22.24 million -8.3%7.7%12.8 $11.12
7/31/20222,180,000 shares $19.90 million +7.4%8.3%13.8 $9.13
7/15/20222,030,000 shares $20.12 million +1.0%7.8%14.4 $9.91
6/30/20222,010,000 shares $15.82 million +2.0%7.7%16.8 $7.87
6/15/20221,970,000 shares $15.62 million -5.3%7.5%16.7 $7.93
5/31/20222,080,000 shares $20.07 million -3.3%8.0%16 $9.65
5/15/20222,150,000 shares $21.26 million -1.4%8.2%14.1 $9.89
4/30/20222,180,000 shares $24.63 million +0.5%8.3%13.4 $11.30
4/15/20222,170,000 shares $27.54 million +0.5%8.3%11.9 $12.69
3/31/20222,160,000 shares $26.24 million +4.9%8.3%9.6 $12.15
3/15/20222,060,000 shares $24.82 million +3.0%7.9%7.9 $12.05
2/28/20222,000,000 shares $19.90 million +3.6%7.7%7.2 $9.95
2/15/20221,930,000 shares $19.59 million -2.5%7.4%6.6 $10.15
1/31/20221,980,000 shares $18.55 million -8.3%7.6%2.4 $9.37
1/15/20222,160,000 shares $21.45 million +11.3%N/A2.7 $9.93
12/31/20211,940,000 shares $23.75 million +0.5%7.4%2.5 $12.24
12/15/20211,930,000 shares $28.27 million -3.5%7.4%2.6 $14.65
11/30/20212,000,000 shares $31.60 million +98.0%8.1%2.9 $15.80
11/15/20211,010,000 shares $14.44 million -34.0%4.2%1.5 $14.30
10/29/20211,530,000 shares $17.55 million +10.9%7.3%11 $11.47
10/15/20211,380,000 shares $15.79 million +0.7%6.6%12.1 $11.44
9/30/20211,370,000 shares $14.28 million -3.5%6.5%11.3 $10.42
9/15/20211,420,000 shares $14.31 million +2.9%6.8%8.4 $10.08
8/31/20211,380,000 shares $15.10 million +4.6%6.6%8.2 $10.94
8/13/20211,320,000 shares $13.66 million -4.4%6.3%8 $10.35
7/30/20211,380,000 shares $11.34 million +5.3%6.6%8.1 $8.22
7/15/20211,310,000 shares $10.00 million +0.8%6.3%7 $7.63
6/30/20211,300,000 shares $11.69 million +14.0%6.2%6.6 $8.99

EYPT Short Interest - Frequently Asked Questions

Short interest is the volume of Eyepoint Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 15,077,303 shares of EYPT short. 18.96% of Eyepoint Pharmaceuticals' shares are currently sold short. Learn More on Eyepoint Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EYPT shares currently have a short interest ratio of 13.8. Learn More on Eyepoint Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.96% of Eyepoint Pharmaceuticals' floating shares are currently sold short.

Eyepoint Pharmaceuticals saw a drop in short interest in June. As of June 15th, there was short interest totaling 15,077,303 shares, a drop of 0.1% from the previous total of 15,097,978 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

18.96% of Eyepoint Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "measuring and control equipment" compare to Eyepoint Pharmaceuticals: Vontier Corporation (7.69%), 10x Genomics (19.10%), Aehr Test Systems (13.65%), Allient Inc. (4.68%), Transcat, Inc. (5.72%), Frequency Electronics, Inc. (11.16%), Cytek Biosciences, Inc. (6.08%), Syntec Optics Holdings, Inc. (4.87%), Prenetics Global Limited (3.89%), 908 Devices Inc. (11.81%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($77.25 billion), Invesco QQQ ($51.70 billion), iShares Russell 2000 ETF ($25.75 billion), Sandisk Corporation ($23.00 billion), Western Digital Corporation ($17.29 billion), Nebius Group N.V. ($13.25 billion), SPDR S&P Biotech ETF ($10.78 billion), KLA Corporation ($10.45 billion), Salesforce Inc. ($9.71 billion), and VanEck Semiconductor ETF ($9.01 billion). View all of the most shorted stocks.

Short selling EYPT is an investing strategy that aims to generate trading profit from Eyepoint Pharmaceuticals as its price is falling. EYPT shares are trading down $0.69 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Eyepoint Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EYPT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EYPT, twice per month. The most recent reporting period available is June, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like EYPT:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:EYPT) was last updated on 6/25/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX IPO “cancelled”?
SpaceX is approaching what could be a $1.6 trillion IPO - potentially the largest in history. But Louis Navell...
InvestorPlace | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
The EPA just put a kill switch on Elon’s empire
A federal EPA permit expires January 2, 2027 - and if Elon Musk's Colossus supercomputer loses power that day,...
Behind the Markets | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely, LLC | Sponsoredtc pixel
Quick favor to ask you
Bill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...
Profits Run | Sponsoredtc pixel
Millionaire trader who went 13-for-13 on Trump in 2025 now turns his attention to Elon.
Hedge fund trader Larry Benedict went 13-for-13 in Q1 2025 - not a single losing trade - and finished the year...
Brownstone Research | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel